$BLUE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in bluebird bio, Inc.. Get notifications about new insider transactions in bluebird bio, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Gift | G | 0.00 | 123,000 | 0 | 123,000 | 0 to 123 K |
| May 13 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Gift | G | 0.00 | 123,000 | 0 | 45,699 | 168.7 K to 45.7 K (-72.91 %) |
| May 05 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 30.15 | 29 | 874 | 40,108 | 40.1 K to 40.1 K (-0.07 %) |
| May 05 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 30.15 | 29 | 874 | 40,108 | 40.1 K to 40.1 K (-0.07 %) |
| May 05 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 30.15 | 39 | 1,176 | 46,829 | 46.9 K to 46.8 K (-0.08 %) |
| May 05 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 30.15 | 39 | 1,176 | 46,829 | 46.9 K to 46.8 K (-0.08 %) |
| May 05 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 30.15 | 444 | 13,387 | 306,692 | 307.1 K to 306.7 K (-0.14 %) |
| May 05 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 30.15 | 38 | 1,146 | 47,922 | 48 K to 47.9 K (-0.08 %) |
| May 05 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 30.15 | 444 | 13,387 | 306,692 | 307.1 K to 306.7 K (-0.14 %) |
| May 05 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 30.15 | 38 | 1,146 | 47,922 | 48 K to 47.9 K (-0.08 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 30.21 | 29 | 876 | 40,137 | 40.2 K to 40.1 K (-0.07 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 30.21 | 444 | 13,411 | 307,136 | 307.6 K to 307.1 K (-0.14 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 30.21 | 39 | 1,178 | 46,868 | 46.9 K to 46.9 K (-0.08 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 30.21 | 29 | 876 | 40,137 | 40.2 K to 40.1 K (-0.07 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 30.21 | 37 | 1,118 | 47,960 | 48 K to 48 K (-0.08 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 30.21 | 42 | 1,269 | 47,787 | 47.8 K to 47.8 K (-0.09 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 30.21 | 444 | 13,411 | 307,136 | 307.6 K to 307.1 K (-0.14 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 30.21 | 39 | 1,178 | 46,868 | 46.9 K to 46.9 K (-0.08 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 30.21 | 37 | 1,118 | 47,960 | 48 K to 48 K (-0.08 %) |
| Apr 07 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 30.21 | 42 | 1,269 | 47,787 | 47.8 K to 47.8 K (-0.09 %) |
| Mar 08 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | M | 5.50 | 203,355 | 1,118,534 | 0 | |
| Mar 08 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Buy | M | 5.50 | 203,355 | 1,118,534 | 307,580 | 104.2 K to 307.6 K (+195.11 %) |
| Mar 08 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | M | 5.50 | 203,355 | 1,118,534 | 0 | |
| Mar 08 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Buy | M | 5.50 | 203,355 | 1,118,534 | 307,580 | 104.2 K to 307.6 K (+195.11 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 29.58 | 444 | 13,134 | 104,225 | 104.7 K to 104.2 K (-0.42 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 29.58 | 34 | 1,006 | 40,166 | 40.2 K to 40.2 K (-0.08 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 29.58 | 42 | 1,242 | 47,829 | 47.9 K to 47.8 K (-0.09 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 29.58 | 38 | 1,124 | 47,997 | 48 K to 48 K (-0.08 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 29.58 | 39 | 1,154 | 46,907 | 46.9 K to 46.9 K (-0.08 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 29.58 | 444 | 13,134 | 104,225 | 104.7 K to 104.2 K (-0.42 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 29.58 | 34 | 1,006 | 40,166 | 40.2 K to 40.2 K (-0.08 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 29.58 | 42 | 1,242 | 47,829 | 47.9 K to 47.8 K (-0.09 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 29.58 | 38 | 1,124 | 47,997 | 48 K to 48 K (-0.08 %) |
| Mar 04 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 29.58 | 39 | 1,154 | 46,907 | 46.9 K to 46.9 K (-0.08 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Option Exercise | A | 28.44 | 25,000 | 711,000 | 25,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Sell | S | 28.16 | 693 | 19,516 | 35,529 | 36.2 K to 35.5 K (-1.91 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Grant | A | 0.00 | 2,141 | 0 | 36,222 | 34.1 K to 36.2 K (+6.28 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Grant | A | 0.00 | 12,500 | 0 | 34,081 | 21.6 K to 34.1 K (+57.92 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Burnett Katy | Principal Accountin ... | Sell | S | 28.16 | 518 | 14,588 | 4,097 | 4.6 K to 4.1 K (-11.22 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Burnett Katy | Principal Accountin ... | Grant | A | 0.00 | 1,427 | 0 | 4,615 | 3.2 K to 4.6 K (+44.76 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Burnett Katy | Principal Accountin ... | Grant | A | 0.00 | 2,000 | 0 | 3,188 | 1.2 K to 3.2 K (+168.35 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | A | 28.44 | 25,000 | 711,000 | 25,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 28.16 | 664 | 18,699 | 46,946 | 47.6 K to 46.9 K (-1.39 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Grant | A | 0.00 | 2,162 | 0 | 47,610 | 45.4 K to 47.6 K (+4.76 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Grant | A | 0.00 | 12,500 | 0 | 45,448 | 32.9 K to 45.4 K (+37.94 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Option Exercise | A | 28.44 | 30,000 | 853,200 | 30,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 28.16 | 749 | 21,093 | 40,200 | 40.9 K to 40.2 K (-1.83 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Grant | A | 0.00 | 2,065 | 0 | 40,949 | 38.9 K to 40.9 K (+5.31 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Grant | A | 0.00 | 15,000 | 0 | 38,884 | 23.9 K to 38.9 K (+62.80 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | A | 28.44 | 20,000 | 568,800 | 20,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 28.16 | 698 | 19,657 | 47,871 | 48.6 K to 47.9 K (-1.44 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Grant | A | 0.00 | 2,271 | 0 | 48,569 | 46.3 K to 48.6 K (+4.91 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 46,298 | 36.3 K to 46.3 K (+27.55 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Option Exercise | A | 28.44 | 27,500 | 782,100 | 27,500 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 28.16 | 665 | 18,727 | 48,035 | 48.7 K to 48 K (-1.37 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Grant | A | 0.00 | 2,165 | 0 | 48,700 | 46.5 K to 48.7 K (+4.65 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Grant | A | 0.00 | 13,750 | 0 | 46,535 | 32.8 K to 46.5 K (+41.94 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | A | 28.44 | 90,000 | 2,559,600 | 90,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Grant | A | 0.00 | 18,000 | 0 | 104,669 | 86.7 K to 104.7 K (+20.77 %) |
| Feb 17 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Sell | S | 45.52 | 1,216 | 55,352 | 21,581 | 22.8 K to 21.6 K (-5.33 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 45.93 | 34 | 1,561 | 23,884 | 23.9 K to 23.9 K (-0.14 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 45.93 | 63 | 2,893 | 36,298 | 36.4 K to 36.3 K (-0.17 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 45.93 | 594 | 27,280 | 86,669 | 87.3 K to 86.7 K (-0.68 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 45.93 | 38 | 1,745 | 32,785 | 32.8 K to 32.8 K (-0.12 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 45.93 | 59 | 2,710 | 32,948 | 33 K to 32.9 K (-0.18 %) |
| Jan 11 2021 | BLUE | bluebird bio, Inc. | Ibrahim Ramy | Option Exercise | A | 48.36 | 4,500 | 217,620 | 4,500 | ||
| Jan 11 2021 | BLUE | bluebird bio, Inc. | Ibrahim Ramy | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K | |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 45.46 | 4,222 | 191,947 | 87,263 | 91.5 K to 87.3 K (-4.61 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 44.76 | 5,873 | 262,867 | 91,485 | 97.4 K to 91.5 K (-6.03 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 44.95 | 333 | 14,969 | 97,358 | 97.7 K to 97.4 K (-0.34 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Sell | S | 45.46 | 397 | 18,049 | 22,797 | 23.2 K to 22.8 K (-1.71 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Sell | S | 44.76 | 552 | 24,707 | 23,194 | 23.7 K to 23.2 K (-2.32 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 45.46 | 759 | 34,507 | 25,103 | 25.9 K to 25.1 K (-2.93 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 44.76 | 1,055 | 47,220 | 25,862 | 26.9 K to 25.9 K (-3.92 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 44.95 | 40 | 1,798 | 26,917 | 27 K to 26.9 K (-0.15 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 45.46 | 1,324 | 60,194 | 36,361 | 37.7 K to 36.4 K (-3.51 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 44.76 | 1,843 | 82,490 | 37,685 | 39.5 K to 37.7 K (-4.66 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 44.95 | 48 | 2,158 | 39,528 | 39.6 K to 39.5 K (-0.12 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 45.46 | 986 | 44,827 | 32,823 | 33.8 K to 32.8 K (-2.92 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 44.76 | 1,372 | 61,409 | 33,809 | 35.2 K to 33.8 K (-3.90 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 44.95 | 43 | 1,933 | 35,181 | 35.2 K to 35.2 K (-0.12 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 45.46 | 538 | 24,459 | 20,609 | 21.1 K to 20.6 K (-2.54 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 44.76 | 749 | 33,524 | 21,147 | 21.9 K to 21.1 K (-3.42 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 44.95 | 42 | 1,888 | 21,896 | 21.9 K to 21.9 K (-0.19 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 45.46 | 1,152 | 52,374 | 33,007 | 34.2 K to 33 K (-3.37 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 44.76 | 1,602 | 71,703 | 34,159 | 35.8 K to 34.2 K (-4.48 %) |
| Jan 08 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 44.95 | 45 | 2,023 | 35,761 | 35.8 K to 35.8 K (-0.13 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Burnett Katy | Principal Accountin ... | Sell | S | 46.09 | 123 | 5,669 | 1,460 | 1.6 K to 1.5 K (-7.77 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Burnett Katy | Principal Accountin ... | Sell | S | 46.09 | 123 | 5,669 | 1,460 | 1.6 K to 1.5 K (-7.77 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 46.50 | 1 | 47 | 26,957 | 27 K to 27 K (0.00 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 46.50 | 1 | 47 | 26,957 | 27 K to 27 K (0.00 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 46.19 | 35 | 1,617 | 26,958 | 27 K to 27 K (-0.13 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 46.19 | 35 | 1,617 | 26,958 | 27 K to 27 K (-0.13 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 46.50 | 1 | 47 | 21,938 | 21.9 K to 21.9 K (0.00 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 46.50 | 1 | 47 | 21,938 | 21.9 K to 21.9 K (0.00 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 46.19 | 37 | 1,709 | 21,939 | 22 K to 21.9 K (-0.17 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 46.19 | 37 | 1,709 | 21,939 | 22 K to 21.9 K (-0.17 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 46.50 | 1 | 47 | 35,224 | 35.2 K to 35.2 K (0.00 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 46.50 | 1 | 47 | 35,224 | 35.2 K to 35.2 K (0.00 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 46.19 | 37 | 1,709 | 35,225 | 35.3 K to 35.2 K (-0.10 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 46.19 | 37 | 1,709 | 35,225 | 35.3 K to 35.2 K (-0.10 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 46.50 | 2 | 93 | 35,806 | 35.8 K to 35.8 K (-0.01 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 46.50 | 2 | 93 | 35,806 | 35.8 K to 35.8 K (-0.01 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 46.19 | 57 | 2,633 | 35,808 | 35.9 K to 35.8 K (-0.16 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 46.19 | 57 | 2,633 | 35,808 | 35.9 K to 35.8 K (-0.16 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 46.50 | 2 | 93 | 39,576 | 39.6 K to 39.6 K (-0.01 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 46.50 | 2 | 93 | 39,576 | 39.6 K to 39.6 K (-0.01 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 46.19 | 62 | 2,864 | 39,578 | 39.6 K to 39.6 K (-0.16 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 46.19 | 62 | 2,864 | 39,578 | 39.6 K to 39.6 K (-0.16 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 46.50 | 14 | 651 | 97,691 | 97.7 K to 97.7 K (-0.01 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 46.50 | 14 | 651 | 97,691 | 97.7 K to 97.7 K (-0.01 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 46.19 | 430 | 19,861 | 97,705 | 98.1 K to 97.7 K (-0.44 %) |
| Dec 04 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 46.19 | 430 | 19,861 | 97,705 | 98.1 K to 97.7 K (-0.44 %) |
| Nov 04 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 54.43 | 4 | 218 | 26,993 | 27 K to 27 K (-0.01 %) |
| Nov 04 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 53.83 | 7 | 377 | 26,997 | 27 K to 27 K (-0.03 %) |
| Nov 04 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 52.51 | 24 | 1,260 | 27,004 | 27 K to 27 K (-0.09 %) |
| Nov 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 54.43 | 4 | 218 | 21,976 | 22 K to 22 K (-0.02 %) |
| Nov 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 53.83 | 7 | 377 | 21,980 | 22 K to 22 K (-0.03 %) |
| Nov 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 52.51 | 26 | 1,365 | 21,987 | 22 K to 22 K (-0.12 %) |
| Oct 06 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 52.77 | 64 | 3,377 | 39,703 | 39.8 K to 39.7 K (-0.16 %) |
| Oct 06 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 52.77 | 38 | 2,005 | 35,299 | 35.3 K to 35.3 K (-0.11 %) |
| Oct 06 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 52.77 | 38 | 2,005 | 22,013 | 22.1 K to 22 K (-0.17 %) |
| Oct 06 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 52.77 | 36 | 1,900 | 27,028 | 27.1 K to 27 K (-0.13 %) |
| Oct 06 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 52.77 | 450 | 23,744 | 98,579 | 99 K to 98.6 K (-0.45 %) |
| Oct 06 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 52.77 | 60 | 3,166 | 35,924 | 36 K to 35.9 K (-0.17 %) |
| Sep 08 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 58.60 | 35 | 2,051 | 27,063 | 27.1 K to 27.1 K (-0.13 %) |
| Sep 08 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 58.60 | 36 | 2,110 | 22,051 | 22.1 K to 22.1 K (-0.16 %) |
| Sep 08 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 58.60 | 36 | 2,110 | 35,337 | 35.4 K to 35.3 K (-0.10 %) |
| Sep 08 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 58.60 | 58 | 3,399 | 35,984 | 36 K to 36 K (-0.16 %) |
| Sep 08 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 58.60 | 41 | 2,403 | 39,767 | 39.8 K to 39.8 K (-0.10 %) |
| Sep 08 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 58.60 | 431 | 25,257 | 99,029 | 99.5 K to 99 K (-0.43 %) |
| Aug 27 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 58.95 | 225 | 13,264 | 22,087 | 22.3 K to 22.1 K (-1.01 %) |
| Aug 11 2020 | BLUE | bluebird bio, Inc. | Torres Denice | Option Exercise | A | 65.77 | 4,500 | 295,965 | 4,500 | ||
| Aug 11 2020 | BLUE | bluebird bio, Inc. | Torres Denice | Grant | A | 0.00 | 2,250 | 0 | 2,750 | 500 to 2.8 K (+450.00 %) | |
| Aug 05 2020 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 61.00 | 82 | 5,002 | 9,512 | 9.6 K to 9.5 K (-0.85 %) |
| Aug 05 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 61.98 | 11 | 682 | 39,808 | 39.8 K to 39.8 K (-0.03 %) |
| Aug 05 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 60.32 | 31 | 1,870 | 39,819 | 39.9 K to 39.8 K (-0.08 %) |
| Aug 05 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 60.98 | 112 | 6,830 | 99,460 | 99.6 K to 99.5 K (-0.11 %) |
| Aug 05 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 60.32 | 332 | 20,026 | 99,572 | 99.9 K to 99.6 K (-0.33 %) |
| Aug 05 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 60.98 | 9 | 549 | 35,373 | 35.4 K to 35.4 K (-0.03 %) |
| Aug 05 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 60.32 | 28 | 1,689 | 35,382 | 35.4 K to 35.4 K (-0.08 %) |
| Jul 22 2020 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 66.38 | 596 | 39,562 | 9,594 | 10.2 K to 9.6 K (-5.85 %) |
| Jul 07 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 61.57 | 443 | 27,277 | 99,904 | 100.3 K to 99.9 K (-0.44 %) |
| Jul 07 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 61.57 | 38 | 2,340 | 22,349 | 22.4 K to 22.3 K (-0.17 %) |
| Jul 07 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 61.57 | 59 | 3,633 | 36,101 | 36.2 K to 36.1 K (-0.16 %) |
| Jul 07 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 61.57 | 42 | 2,586 | 39,850 | 39.9 K to 39.9 K (-0.11 %) |
| Jul 07 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 61.57 | 38 | 2,340 | 35,410 | 35.4 K to 35.4 K (-0.11 %) |
| Jul 07 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 61.57 | 36 | 2,217 | 27,133 | 27.2 K to 27.1 K (-0.13 %) |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Vachon Mark | Option Exercise | A | 64.09 | 3,000 | 192,270 | 3,000 | ||
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Vachon Mark | Grant | A | 0.00 | 1,500 | 0 | 3,657 | 2.2 K to 3.7 K (+69.54 %) |